patent protection

President Biden said that he's considering suspending the patents of the COVID-19 vaccines. If this occurs, there will be very little incentive for these drug makers to jump into research again, when, or if, a new, resistant variant emerges. These are companies, not charities.
Dr. Josh Bloom on Science 2.0, December 2, 2014. Just for yucks, let s go back a few years and see how well people did in forecasting drug prices in the future. Within the past decade, we began to hear the term patent cliff the consequence of most blockbuster drugs losing patent protection during a short period of time. Perennial critics of the pharmaceutical industry were experiencing paroxysms of joy as the holy grail of health care savings generic drug companies became